The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study.
Erin Lynn Van BlariganStacey A KenfieldLucy K TantumLisa A Cadmus-BertramPeter R CarrollJune Maylin ChanPublished in: JMIR cancer (2017)
Among prostate cancer survivors, the Fitbit One's activity and step measurements were well correlated with the ActiGraph GT3X+ and Omron pedometer. However, the Fitbit One measured two times more MVPA on average compared with the ActiGraph.